Systems of Care: Nile AI Tackles the Biggest Problem in Epilepsy

article image
ARTICLE SUMMARY:

Many epilepsy patients cannot live the lives they want because of the unpredictability of seizures. The founders of Nile AI believe that doesn’t have to be the case. Spun-off from UCB, a leader in the development of epilepsy drugs, Nile AI is developing a systematic solution in a platform that unites all epilepsy stakeholders in the goal of rapidly getting each patient into the therapy that works best for them

In many areas of medicine, despite the availability of excellent drug or device therapies, patients don't experience the best possible outcomes because of systemic problems in care delivery. Increasingly, therapy developers are wrapping their arms around this healthcare problem with digital health and health IT solutions. Orthopedic companies were probably the first to adopt this strategy, with digital health collaborations that reach joint reconstruction patients in the period following surgery, to make sure they comply with the rehab that fosters good outcomes. In neurology, Medtronic plc was early in taking on some of the delivery gaps in time-sensitive ischemic stroke, with its Stroke Care Solution, one element of which is a partnership with the artificial intelligence company Viz.Ai, which offers a hospital triage technology to get stroke patients into the proper treatment ASAP. Cardiology companies, too, are thus broadening their focus. In late February, Terumo Corp. acquired Health Outcomes Sciences, a predictive analytics company providing patient-specific insights at the point of care. 

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.


Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to MedTech Strategist:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to MedTech Strategist
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite

Questions?

We're here to help! Please contact us at: